Core Laboratories
CLB
163 hedge funds and large institutions have $1.02B invested in Core Laboratories in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 25 closing their positions.
622% more call options, than puts
Call options by funds: $1.83M | Put options by funds: $253K
16% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 25
13% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 48
10% more capital invested
Capital invested by funds: $921M → $1.02B (+$94.5M)
1% more funds holding
Funds holding: 161 → 163 (+2)
0.77% more ownership
Funds ownership: 97.93% → 98.7% (+0.77%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.2M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.11M |
| 3 |
ACM
Advisors Capital Management
Ridgewood,
New Jersey
|
+$5.35M |
| 4 |
BBL
Beck Bode LLC
Dedham,
Massachusetts
|
+$5.14M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WI
Wintrust Investments
Chicago,
Illinois
|
-$8.1M |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
-$7.29M |
| 3 |
FAM
Fred Alger Management
New York
|
-$6.35M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$5.16M |
| 5 |
AI
Ariel Investments
Chicago,
Illinois
|
-$4.54M |
CLB Hedge Fund Activity: Q1 2023 in Review
163 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2023, worth a combined $1.02B — up 10% from $921M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new CLB positions and 25 closed out — a net gain of 4 holders — while 54 added to existing stakes and 48 trimmed.
The largest buyer was Ameriprise, adding an estimated $13.2M. The largest seller was Wintrust Investments, exiting entirely with an estimated $8.1M sold.
- 163 institutional investors held Core Laboratories (CLB) as of Q1 2023, up from 161 in Q4 2022.
- Funds reported $1.02B of Core Laboratories stock for Q1 2023, up 10% quarter-over-quarter.
- 29 funds opened new Core Laboratories positions in Q1 2023 and 25 closed out, a net change of +4 holders.
- The largest Core Laboratories buyer in Q1 2023 was Ameriprise, an estimated $13.2M added.
- The largest Core Laboratories seller in Q1 2023 was Wintrust Investments, an estimated $8.1M sold.
Based on aggregated 13F filings for Q1 2023.